Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
27.54 USD | -1.33% | +3.65% | -4.84% |
May. 23 | Supernus Pharmaceuticals Reports 'Clinical Utility' From Epilepsy Treatment Study | MT |
May. 23 | Transcript : Supernus Pharmaceuticals, Inc. - Special Call |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.84% | 1.51B | |
+19.64% | 80.67B | |
+13.63% | 9.17B | |
-15.14% | 4.86B | |
+45.17% | 4.55B | |
+15.70% | 4.34B | |
+10.13% | 2.38B | |
-26.13% | 2.2B | |
+15.73% | 2.1B | |
-40.52% | 1.86B |
- Stock Market
- Equities
- SUPN Stock
- News Supernus Pharmaceuticals, Inc.
- Transcript : Supernus Pharmaceuticals, Inc., Q4 2021 Earnings Call, Feb 28, 2022